|
ZNF780B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64079860809352E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.83517653798526E-12 |
| Normal-vs-Stage2 |
5.30959999966996E-07 |
| Normal-vs-Stage3 |
1.64623870091418E-12 |
| Normal-vs-Stage4 |
1.1914999997753E-07 |
| Stage1-vs-Stage2 |
7.832200E-01 |
| Stage1-vs-Stage3 |
2.251500E-02 |
| Stage1-vs-Stage4 |
2.642200E-01 |
| Stage2-vs-Stage3 |
7.413900E-02 |
| Stage2-vs-Stage4 |
2.476400E-01 |
| Stage3-vs-Stage4 |
7.678200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.43995926293883E-13 |
| Normal-vs-AfricanAmerican |
1.183360E-04 |
| Normal-vs-Asian |
1.10060000002576E-06 |
| Caucasian-vs-AfricanAmerican |
7.678000E-01 |
| Caucasian-vs-Asian |
2.611400E-01 |
| AfricanAmerican-vs-Asian |
6.275200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.5094000190058E-09 |
| Normal-vs-Female |
1.62903024403249E-12 |
| Male-vs-Female |
4.404800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.40180003558055E-09 |
| Normal-vs-Age(41-60Yrs) |
1.31350486043402E-11 |
| Normal-vs-Age(61-80Yrs) |
5.81349968165057E-10 |
| Normal-vs-Age(81-100Yrs) |
7.143000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.200600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.971200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.360400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.840400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.069400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.805000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.51450000043896E-07 |
| Classical-VS-Follicular |
6.589000E-01 |
| Classical-VS-Other |
7.248000E-01 |
| Classical-VS-Normal |
1.65419999920147E-08 |
| Tall-VS-Follicular |
1.78564999999686E-05 |
| Tall-VS-Other |
9.279900E-02 |
| Tall-VS-Normal |
2.85327317328665E-14 |
| Follicular-VS-Other |
8.634200E-01 |
| Follicular-VS-Normal |
3.82880000038277E-07 |
| Other-VS-Normal |
3.765900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.30360208475622E-11 |
| Normal-vs-N1 |
3.2348000000848E-07 |
| N0-vs-N1 |
5.687000E-01 |
|
|
